Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | nomifensine | 3278 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | nomifensine | 3278 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | nomifensine | 3278 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | nomifensine | 3278 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | acetylsalicylsalicylic acid | 10745 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | acetylsalicylsalicylic acid | 10745 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | acetylsalicylsalicylic acid | 10745 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | acetylsalicylsalicylic acid | 10745 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | acetylsalicylsalicylic acid | 10745 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | spironolactone | 5833 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | spironolactone | 5833 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | spironolactone | 5833 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | spironolactone | 5833 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | nalbuphine | 5311304 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | nalbuphine | 5311304 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | nalbuphine | 5311304 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | canrenoic acid | 656615 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | canrenoic acid | 656615 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | canrenoic acid | 656615 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | canrenoic acid | 656615 | drug-path |